A month after the FDA kept its clinical hold on Solid Biosciences’ experimental gene therapy treatment, the biotech’s former chief medical officer has landed at Apic.
Jorge Quiroz, M.D., had been CMO of Solid but
CHALLENGING CASE
Primary insomnia is a decreased ability to fall asleep and/or stay asleep, with resulting daytime effects of sleep deprivation, such as fatigue, dozing off, and irritability. The sleep problems of primary insomnia are not associated with lifestyle…
Abivertinib, an investigational COVID-19 therapy, was cleared by the Food and Drug Administration (FDA) for a Phase 2 study for efficacy and safety for hospitalized COVID-19 patients who have moderate to severe pulmonary symptoms.
Specifically, the research is going to look…
